Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
A Real-World Retrospective Cohort Study on the Clinical Effect of Silymarin (Legalon) on Liver Damage and Diseases Using a Domestic Multicenter Common Data Model
Gut and Liver
May 2026
Jang B.K.
Open Access
Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis
Gastro Hep Advances
January 2026
Chen Liang A.
Open Access
Comparative Efficacy of Herbal Products on Metabolic Parameters in Metabolic-Dysfunction Associated Liver Disease: A Systematic Review and Network Meta-Analysis
Gastro Hep Advances
January 2026
Sairaj R.T.
Open Access
Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury
BMC Complementary Medicine and Therapies
December 2025
Shahsavari K.
Open Access
Expert consensus on the off-label clinical use of glucose-lowering medications (2025 edition)
Chinese Journal of Diabetes Mellitus
20 November 2025
Feng B.
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease
Cochrane Database of Systematic Reviews
24 June 2025
Wang C.
All Open Access, Green
Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta-Analysis
Journal of Evidence Based Medicine
June 2025
Ren Q.
Open Access
Lactobacillus rhamnosus GG Combined with Metformin Alleviates Alcohol-Induced Liver Inflammation in Mice by Maintaining the Intestinal Barrier and Regulating Treg/Th1 Cells
Journal of Medicinal Food
1 April 2025
Zhu Y.
Effects of silymarin supplementation in late pregnancy and lactation on reproductive performance, colostrum quality, blood biochemistry and inflammation levels of sows
Tropical Animal Health and Production
March 2025
Cong G.
Effects of silymarin on insulin resistance and sensitivity: A systematic review and meta-analysis of randomized controlled trials
Diabetes Research and Clinical Practice
February 2025
Yin S.
Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD
Cell Biochemistry and Function
September 2024
Ezhilarasan D.
Open Access
Effects of different natural products in patients with non-alcoholic fatty liver disease—A network meta-analysis of randomized controlled trials
Phytotherapy Research
July 2024
Liu H.
Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta-analysis of randomized controlled trials
Obesity Reviews
June 2024
Wang H.
Open Access
Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
Canadian Liver Journal
February 2024
Malik A.
All Open Access, Green
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review
European Journal of Clinical Pharmacology
January 2024
Zachou M.
Open Access
Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease
Foods
September 2023
Huang W.
Open Access
Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysis
Frontiers in Pharmacology
9 January 2023
Jin D.
Open Access
Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials
Frontiers in Endocrinology
2023
Wang Z.
Open Access
Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,
Clinics and Research in Hepatology and Gastroenterology
January 2023
Zou C.y.
Open Access
Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Scientia Pharmaceutica
2023
Nucera S.
Open Access
Silybin induces endothelium-dependent vasodilation via TRPV4 channels in mouse mesenteric arteries
Hypertension Research
December 2022
Wen X.